Skip to main content

Amicus Therapeutics, Inc.

FOLDDelisted Apr 27, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001178879

Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2023

Institutional positions in Amicus Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
229
+14 vs. Q2 2023
Shares held
298.7M
+834.6K (+0.3%) vs. Q2 2023
Total value
$3.63B
−$105.1M (−2.8%) vs. Q2 2023
New holders
33
95 more added
Sold out
19
66 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 229 institutions
Q1 2021: 259 institutionsQ2 2021: 235 institutionsQ3 2021: 238 institutionsQ4 2021: 224 institutionsQ1 2022: 216 institutionsQ2 2022: 213 institutionsQ3 2022: 222 institutionsQ4 2022: 230 institutionsQ1 2023: 226 institutionsQ2 2023: 216 institutionsQ3 2023: 229 institutionsQ4 2023: 229 institutionsQ1 2024: 254 institutionsQ2 2024: 259 institutionsQ3 2024: 293 institutionsQ4 2024: 290 institutionsQ1 2025: 286 institutionsQ2 2025: 272 institutionsQ3 2025: 287 institutionsQ4 2025: 332 institutionsQ1 2026: 298 institutionsQ2 2026: 2 institutions
Value heldQ3 2023: $3.63B
Q1 2021: $2.74BQ2 2021: $2.67BQ3 2021: $2.80BQ4 2021: $3.48BQ1 2022: $2.87BQ2 2022: $3.28BQ3 2022: $3.05BQ4 2022: $3.57BQ1 2023: $3.30BQ2 2023: $3.86BQ3 2023: $3.63BQ4 2023: $4.53BQ1 2024: $3.79BQ2 2024: $3.13BQ3 2024: $3.31BQ4 2024: $2.88BQ1 2025: $2.55BQ2 2025: $1.83BQ3 2025: $2.46BQ4 2025: $4.57BQ1 2026: $4.81BQ2 2026: $11.5K
Institutions holding FOLD and their total value by quarter
QuarterHoldersValue
Q2 20262$11.5K
Q1 2026298$4.81B
Q4 2025332$4.57B
Q3 2025287$2.46B
Q2 2025272$1.83B
Q1 2025286$2.55B
Q4 2024290$2.88B
Q3 2024293$3.31B
Q2 2024259$3.13B
Q1 2024254$3.79B
Q4 2023229$4.53B
Q3 2023229$3.63B
Q2 2023216$3.86B
Q1 2023226$3.30B
Q4 2022230$3.57B
Q3 2022222$3.05B
Q2 2022213$3.28B
Q1 2022216$2.87B
Q4 2021224$3.48B
Q3 2021238$2.80B
Q2 2021235$2.67B
Q1 2021259$2.74B

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding FOLD in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Massachusetts Financial Services Co1,821,959$22.2M0.01%+340,673+23.0%Added
Novo Holdings A/S2,095,900$25.5M1.88%00.0%Unchanged
Charles Schwab Investment Management Inc2,178,691$26.5M0.01%+72,674+3.5%Added
Bank of America Corp2,244,633$27.3M0.00%−134,269−5.6%Reduced
Boxer Capital, LLC2,325,000$28.3M1.51%00.0%Unchanged
Norges Bank2,416,317$29.4M0.01%−870,000−26.5%Reduced
Goldman Sachs Group Inc2,518,084$30.6M0.01%−278,037−9.9%Reduced
FMR LLC2,778,232$33.8M0.00%+468,611+20.3%Added
Northern Trust Corp2,831,930$34.4M0.01%+15,608+0.6%Added
Victory Capital Management Inc2,949,206$35.9M0.04%+2,350,262+392.4%Added
Balyasny Asset Management LLC3,385,432$41.2M0.12%+160,399+5.0%Added
Artal Group S.A.4,062,567$49.4M2.15%−500,000−11.0%Reduced
American Century Companies Inc4,343,870$52.8M0.04%+429,257+11.0%Added
Fiera Capital Corp5,085,871$61.8M0.20%+106,086+2.1%Added
Geode Capital Management, LLC5,606,166$68.2M0.01%+210,560+3.9%Added
Macquarie Group Ltd7,212,652$87.7M0.11%+290,671+4.2%Added
Wellington Management Group LLP7,523,689$91.5M0.02%−296,607−3.8%Reduced
Pictet Asset Management Holding SA8,397,511$102.1M0.13%+8,397,511New
William Blair Investment Management, LLC10,376,763$126.2M0.42%+8,070,098+349.9%Added
Palo Alto Investors LP10,524,022$128.0M12.11%00.0%Unchanged
Morgan Stanley10,748,692$130.7M0.01%−2,312,116−17.7%Reduced
State Street Corp11,372,436$138.3M0.01%+193,194+1.7%Added
JPMorgan Chase & Co13,009,429$158.2M0.02%−432,962−3.2%Reduced
Janus Henderson Group PLC14,934,021$181.6M0.12%+10,433+0.1%Added
Redmile Group, LLC16,944,621$206.0M9.80%−2,622,340−13.4%Reduced
BlackRock Inc.20,941,777$254.7M0.01%+43,184+0.2%Added
Vanguard Group Inc27,131,873$329.9M0.01%+107,456+0.4%Added
Avoro Capital Advisors LLC27,400,000$333.2M5.20%00.0%Unchanged
Perceptive Advisors LLC27,692,917$336.7M11.32%+30,000+0.1%Added
OrbiMed Advisors LLC0$00.00%−1,856,400−100.0%Sold out
Integral Health Asset Management, LLC0$00.00%−387,000−100.0%Sold out
Bank of Montreal0$00.00%−290,517−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−235,676−100.0%Sold out
Millennium Management LLC0$00.00%−74,680−100.0%Sold out
HighVista Strategies LLC0$00.00%−62,581−100.0%Sold out
Ergoteles LLC0$00.00%−60,549−100.0%Sold out
Readystate Asset Management LP0$00.00%−26,840−100.0%Sold out
CIBC Private Wealth Group, LLC0$00.00%−24,431−100.0%Sold out
XTX Topco Ltd0$00.00%−21,416−100.0%Sold out
NinePointTwo Capital0$00.00%−19,996−100.0%Sold out
Alberta Investment Management Corp0$00.00%−13,544−100.0%Sold out
State of Wyoming0$00.00%−13,049−100.0%Sold out
Calton & Associates, Inc.0$00.00%−10,923−100.0%Sold out
Guerra Pan Advisors, LLC0$00.00%−10,665−100.0%Sold out
Harbor Investment Advisory, LLC0$00.00%−5,324−100.0%Sold out
Pinebridge Investments, L.P.0$00.00%−3,091−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−725−100.0%Sold out
Valley National Advisers Inc0$00.00%−20−100.0%Sold out
Pictet Asset Management SA––––Not filed